Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.

MLA

Wu, Yu-Tuan, et al. “Hepatitis B Virus Reactivation and Antiviral Prophylaxis during Lung Cancer Chemotherapy: A Systematic Review and Meta-Analysis.” PloS One, vol. 12, no. 6, June 2017, p. e0179680. EBSCOhost, https://doi.org/10.1371/journal.pone.0179680.

APA

Wu, Y.-T., Li, X., Liu, Z.-L., Xu, Z., Dai, W., Zhang, K., Wu, J.-S., Arshad, B., Wu, K.-N., & Kong, L.-Q. (2017). Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis. PloS One, 12(6), e0179680. https://doi.org/10.1371/journal.pone.0179680

Chicago

Wu, Yu-Tuan, Xin Li, Zi-Li Liu, Zhou Xu, Wei Dai, Ke Zhang, Jiu-Song Wu, Bilal Arshad, Kai-Nan Wu, and Ling-Quan Kong. 2017. “Hepatitis B Virus Reactivation and Antiviral Prophylaxis during Lung Cancer Chemotherapy: A Systematic Review and Meta-Analysis.” PloS One 12 (6): e0179680. doi:10.1371/journal.pone.0179680.